Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesAbnormal findings on examination of other body fluids, substances and tissues, without diagnosisICD-10-CM r86-abnormal-findings-male-genital-organs
    Ask Trek AI about this page

    ICD-10-CM Code For Abnormal Findings In Specimens From Male Genital Organs: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group R86 includes nonspecific or abnormal findings in specimens obtained from male genital organs, covering unexpected laboratory or pathology results such as abnormal semen analysis or tissue findings without a definitive diagnosis. These ICD-10-CM diagnosis codes are used to document clinical scenarios where specimen examination yields abnormal or inconclusive results, capturing the need for further evaluation or monitoring of male reproductive organs. Accurate coding within the ICD-10-CM R86 group supports complete clinical documentation and appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Abnormal Findings In Specimens From Male Genital Organs: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM R86: Abnormal Findings In Specimens From Male Genital Organs Overview

    This code group represents abnormal laboratory or pathology findings identified in specimens taken from male genital organs, such as semen, prostate, testes, or other related tissues. These entries capture unexpected or nonspecific results observed on examination of specimens when a definitive diagnosis is not established. Accurate coding matters for reimbursement because it documents the reason for testing and supports medical necessity for laboratory and pathology services.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use a code from this group when laboratory or pathology examination of a specimen from a male genital organ shows abnormal or unexpected results but no definitive clinical diagnosis is yet documented. These codes are appropriate for reporting the clinical finding that prompted testing or further diagnostic evaluation, and for billing laboratory or pathology services associated with the specimen examination.

    ICD-10-CM Codes

    10 rows

    ICD-10-CM CodeDescription
    R86.0Abnormal level of enzymes in specimens from male genital organs
    R86.1Abnormal level of hormones in specimens from male genital organs
    R86.2Abnormal level of other drugs, medicaments and biological substances in specimens from male genital organs
    R86.3Abnormal level of substances chiefly nonmedicinal as to source in specimens from male genital organs
    R86.4Abnormal immunological findings in specimens from male genital organs
    R86.5Abnormal microbiological findings in specimens from male genital organs
    R86.6Abnormal cytological findings in specimens from male genital organs
    R86.7Abnormal histological findings in specimens from male genital organs
    R86.8Other abnormal findings in specimens from male genital organs
    R86.9Unspecified abnormal finding in specimens from male genital organs

    DRG Codes

    2 rows

    DRG CodeDescription
    729Other Male Reproductive System Diagnoses with CC/MCC
    730Other Male Reproductive System Diagnoses without CC/MCC

    Typical Clinical Scenarios

    • A 28-year-old man presents to urgent care with new-onset painless penile discharge after unprotected sex. A urethral swab is obtained and sent to the lab; the report returns with abnormal cytologic findings in the specimen without a definitive infectious organism identified, prompting assignment of a code to indicate an abnormal finding on examination of the male genital specimen. Typical codes: R86.0, R86.9
    • A 55-year-old male undergoing evaluation for infertility provides a semen sample that shows abnormal cells and abnormal semen analysis results without a diagnosed underlying malignancy or specific infectious etiology. The abnormal laboratory specimen findings are documented to explain the cause of further fertility workup and counseling. Typical codes: R86.2, R86.9
    • A 62-year-old man with a history of prostate enlargement has a transrectal needle biopsy of the prostate for rising PSA; pathology reports atypical or abnormal cells in the prostate tissue specimen but no definitive cancer diagnosis on initial review. Because the specimen demonstrates abnormal findings without a confirmed diagnosis, an appropriate code from this group is assigned to capture the abnormal pathology result. Typical codes: R86.3, R86.9

    Related Codes

    R83-ABNORMAL-FINDINGS-CEREBROSPINAL-FLUID

    ICD-10-CM Code For Abnormal Findings In Cerebrospinal Fluid: Group Overview

    R84-ABNORMAL-RESPIRATORY-SPECIMEN-FINDINGS

    ICD-10-CM Code For Abnormal Findings In Specimens From Respiratory Organs And Thorax: Group Overview

    R85-ABNORMAL-FINDINGS-DIGESTIVE-ORGANS

    ICD-10-CM Code For Abnormal Findings In Specimens From Digestive Organs And Abdominal Cavity: Group Overview

    R87-ABNORMAL-FINDINGS-FEMALE-GENITAL

    ICD-10-CM Code For Abnormal Findings In Specimens From Female Genital Organs: Group Overview

    R88-ABNORMAL-FINDINGS-IN-BODY-FLUIDS

    ICD-10-CM Code For Abnormal Findings In Other Body Fluids And Substances: Group Overview

    R89-ABNORMAL-FINDINGS-IN-SPECIMENS

    ICD-10-CM Code For Abnormal Findings In Specimens From Other Organs Systems And Tissues: Group Overview

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.